DAVID POPLACK to Antineoplastic Agents, Phytogenic
This is a "connection" page, showing publications DAVID POPLACK has written about Antineoplastic Agents, Phytogenic.
Connection Strength
0.033
-
Phase I trial of docetaxel administered as a 1-hour infusion in children with refractory solid tumors: a collaborative pediatric branch, National Cancer Institute and Children's Cancer Group trial. J Clin Oncol. 1997 Apr; 15(4):1538-43.
Score: 0.027
-
Phase I/II study of 72-hour infusional paclitaxel and doxorubicin with granulocyte colony-stimulating factor in patients with metastatic breast cancer. J Clin Oncol. 1996 Mar; 14(3):774-82.
Score: 0.006